查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434509

成癮疾病治療藥物市場：按藥物類型、治療方法和最終用戶分類 - 全球預測 2024-2030

Addiction Disorders Drugs Market by Drug Type (Alcohol, Marijuana, Prescription & Over-the-Counter Medications), Treatment (Counseling & Behavioral Therapies, Detoxification, Medications), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年成癮疾病治療市場規模為254.6億美元，2024年達到270.8億美元，2030年預計將達到394.7億美元，複合年成長率為6.46%。

治療成癮性疾病藥物的全球市場

主要市場統計
基準年[2023] 254.6億美元
預測年份 [2024] 270.8億美元
預測年份 [2030] 394.7億美元
複合年成長率（%） 6.46%
成癮疾病治療藥物市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估成癮疾病藥物市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對成癮疾病治療藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-成癮疾病治療藥物市場的市場規模與預測是多少？

2-在成癮疾病治療藥物市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-成癮疾病治療藥物市場的技術趨勢和法律規範是什麼？

4-成癮疾病治療藥物市場主要供應商的市場佔有率是多少？

5-進入成癮疾病藥物市場的適當型態或策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 所有年齡層中酒精、菸草和毒品等成癮物質的盛行率增加
      • 政府干涉和鼓勵遏止成癮
      • 核准的藥物數量不斷增加，尼古丁與其他興奮劑合併使用的情況也越來越多
    • 抑制因素
      • 新興國家對成癮治療產品的認知有限
      • 與使用美沙酮相關的多種副作用
    • 機會
      • 錠劑、舌下膜劑和植入等創新藥物的供應
    • 任務
      • 成癮治療藥物的法律義務
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 成癮疾病治療藥物市場（依藥物類型）

  • 酒精
  • 大麻
  • 處方藥和成藥
  • 合成大麻素
  • 煙草/尼古丁和電子煙

第7章 成癮疾病治療藥物市場（依治療分類）

  • 諮商與行為治療
  • 排毒
  • 藥品
  • 復健計劃
  • 自助小組

第8章成癮疾病治療藥物市場：依最終使用者分類

  • 醫院和診所
  • 住宅治療中心

第9章 北美和南美成癮疾病治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區成癮疾病治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲治療成癮疾病的藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Accord Healthcare Limited
    • Alkermes PLC
    • Aurobindo Pharma Limited
    • BioCorRx Inc.
    • Cipla Limited
    • Consern Pharma Limited
    • GlaxoSmithKline PLC
    • Insys Therapeutics
    • Mallinckrodt Pharmaceuticals
    • Medtronic PLC
    • Novartis AG
    • Perrigo Company PLC
    • Pfizer, Inc
    • Psychemedics Corporation
    • Purdue Pharma LP
    • Reckitt Benckiser Pharmaceuticals, Inc.
    • Sun Pharmaceutical Industries Limited
    • Takeda Pharmaceutical Company Ltd
    • Teva Pharmaceutical Industries, Ltd
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-434CCDA05186

[193 Pages Report] The Addiction Disorders Drugs Market size was estimated at USD 25.46 billion in 2023 and expected to reach USD 27.08 billion in 2024, at a CAGR 6.46% to reach USD 39.47 billion by 2030.

Global Addiction Disorders Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 25.46 billion
Estimated Year [2024] USD 27.08 billion
Forecast Year [2030] USD 39.47 billion
CAGR (%) 6.46%
Addiction Disorders Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Addiction Disorders Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Addiction Disorders Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Addiction Disorders Drugs Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare Limited, Alkermes PLC, Aurobindo Pharma Limited, BioCorRx Inc., Cipla Limited, Consern Pharma Limited, GlaxoSmithKline PLC, Insys Therapeutics, Mallinckrodt Pharmaceuticals, Medtronic PLC, Novartis AG, Perrigo Company PLC, Pfizer, Inc, Psychemedics Corporation, Purdue Pharma L.P., Reckitt Benckiser Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Ltd, and Teva Pharmaceutical Industries, Ltd.

Market Segmentation & Coverage

This research report categorizes the Addiction Disorders Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • Alcohol
    • Marijuana
    • Prescription & Over-the-Counter Medications
    • Synthetic Cannabinoids
    • Tobacco/Nicotine & Vaping
  • Treatment
    • Counseling & Behavioral Therapies
    • Detoxification
    • Medications
    • Rehabilitation Programs
    • Self-Help Groups
  • End-user
    • Hospital & Clinics
    • Residential Treatment Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Addiction Disorders Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Addiction Disorders Drugs Market?

3. What are the technology trends and regulatory frameworks in the Addiction Disorders Drugs Market?

4. What is the market share of the leading vendors in the Addiction Disorders Drugs Market?

5. Which modes and strategic moves are suitable for entering the Addiction Disorders Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Addiction Disorders Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalences of addictive substances such as alcohol, tobacco, and drugs among all age groups
      • 5.1.1.2. Government intervention and encouragement to curb addiction disorders
      • 5.1.1.3. Rising number of approved medicines and the increased use of nicotine with other stimulants
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness about addiction treatment products in developing countries
      • 5.1.2.2. Multiple side-effects associated with the use of methadone
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of innovative drugs in the form of pills, sublingual films, and implants
    • 5.1.4. Challenges
      • 5.1.4.1. Legal obligations for addiction treatment products
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Addiction Disorders Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Alcohol
  • 6.3. Marijuana
  • 6.4. Prescription & Over-the-Counter Medications
  • 6.5. Synthetic Cannabinoids
  • 6.6. Tobacco/Nicotine & Vaping

7. Addiction Disorders Drugs Market, by Treatment

  • 7.1. Introduction
  • 7.2. Counseling & Behavioral Therapies
  • 7.3. Detoxification
  • 7.4. Medications
  • 7.5. Rehabilitation Programs
  • 7.6. Self-Help Groups

8. Addiction Disorders Drugs Market, by End-user

  • 8.1. Introduction
  • 8.2. Hospital & Clinics
  • 8.3. Residential Treatment Centers

9. Americas Addiction Disorders Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Addiction Disorders Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Addiction Disorders Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Accord Healthcare Limited
    • 13.1.2. Alkermes PLC
    • 13.1.3. Aurobindo Pharma Limited
    • 13.1.4. BioCorRx Inc.
    • 13.1.5. Cipla Limited
    • 13.1.6. Consern Pharma Limited
    • 13.1.7. GlaxoSmithKline PLC
    • 13.1.8. Insys Therapeutics
    • 13.1.9. Mallinckrodt Pharmaceuticals
    • 13.1.10. Medtronic PLC
    • 13.1.11. Novartis AG
    • 13.1.12. Perrigo Company PLC
    • 13.1.13. Pfizer, Inc
    • 13.1.14. Psychemedics Corporation
    • 13.1.15. Purdue Pharma L.P.
    • 13.1.16. Reckitt Benckiser Pharmaceuticals, Inc.
    • 13.1.17. Sun Pharmaceutical Industries Limited
    • 13.1.18. Takeda Pharmaceutical Company Ltd
    • 13.1.19. Teva Pharmaceutical Industries, Ltd
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ADDICTION DISORDERS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ADDICTION DISORDERS DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ADDICTION DISORDERS DRUGS MARKET DYNAMICS
  • FIGURE 7. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ADDICTION DISORDERS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ADDICTION DISORDERS DRUGS MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRESCRIPTION & OVER-THE-COUNTER MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ADDICTION DISORDERS DRUGS MARKET SIZE, BY SYNTHETIC CANNABINOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TOBACCO/NICOTINE & VAPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 12. ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNSELING & BEHAVIORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DETOXIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ADDICTION DISORDERS DRUGS MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REHABILITATION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ADDICTION DISORDERS DRUGS MARKET SIZE, BY SELF-HELP GROUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ADDICTION DISORDERS DRUGS MARKET SIZE, BY RESIDENTIAL TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 148. ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. ADDICTION DISORDERS DRUGS MARKET LICENSE & PRICING